# Cipla LTD · 66-41 · INDIA — FDA import alert red lists: firms subject to detention without physical examination

For Cipla LTD · 66-41 · INDIA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is INDIA; product is Tadacip 20 | Tadacip 20; product code is 66 S - - 51 Tadalafil | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 03/14/2017; address is Khasra No. 509/1-2 & 520 , Vii-Bhagwanpur , Bhagwanpur, Uttaranchal INDIA, verified against its source on 2026-09-16.

- **Firm:** Cipla LTD _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** INDIA _(verified: appears in the quote below)_
- **Address:** Khasra No. 509/1-2 & 520 , Vii-Bhagwanpur , Bhagwanpur, Uttaranchal INDIA _(verified: appears in the quote below)_
- **Date published:** 03/14/2017 _(verified: appears in the quote below)_
- **Product code:** 66 S - - 51 Tadalafil | 66 V - - 99 Miscellaneous Patent Medicines, Etc. _(verified: each item appears in the quote below)_
- **Product:** Tadacip 20 | Tadacip 20 _(verified: each item appears in the quote below)_

## What the source says

> Cipla LTD Date Published : 03/14/2017 Khasra No. 509/1-2 & 520 , Vii-Bhagwanpur , Bhagwanpur, Uttaranchal INDIA 66 S - - 51 Tadalafil Date Published: 03/14/2017 Desc: Tadacip 20 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 03/14/2017 Desc: Tadacip 20

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).